Cui Jianfeng, Yu Meng, Zhang Ning, Wang Shiyu, Zhu Yaofeng, Chen Shouzhen, Zhu Kejia, Du Jian, Zhao Hongda, Liu Xigao, Chen Pengxiang, Wang Wenbo, Zhang Dongqing, Shi Benkang
Department of Urology, Qilu Hospital of Shandong University, Jinan, P.R. China.
Department of Radiation Oncology, Qilu Hospital, Shandong University, Jinan, P.R. China.
Oncotarget. 2017 Mar 22;8(40):68964-68973. doi: 10.18632/oncotarget.16483. eCollection 2017 Sep 15.
This study is to clarify the prognostic value of preoperative plasma fibrinogen and serum albumin level, as known as FA score, in a cohort of Chinese patients with upper urinary tract urothelial carcinoma (UTUC). We retrospectively evaluated clinicopathological data on 169 patients who underwent surgery between 2006 and 2013. The FA score was calculated based on cutoff values of 3.53g/L for fibrinogen and 43.56 g/L for albumin. Overall survival and cancer specific survival was assessed using the Kaplan-Meier method and the equivalences of the curves were tested by log-rank tests. The Cox proportional hazards regression model was applied in univariate and multivariate analyses. In univariate analysis, tumor size, tumor grade, pathological T stage and FA score were significantly associated with overall survival and cancer specific survival, and multivariate Cox proportional hazards regression analysis identified FA score (score 1: HR=3.486, 95%CI 1.358-8.948, =0.009; HR=3.485, 95%CI 1.363-8.913, =0.009, respectively; score 2: HR=5.509, 95%CI 2.144-14.158, <0.001; HR=5.521, 95%CI 2.074-14.697, =0.001, respectively) was an independent predictor for overall survival and cancer specific survival. The evaluation of preoperative FA score can be regarded as an independent prognostic factor for predicting overall survival and cancer specific survival in UTUC. The fibrinogen and albumin levels are low cost and easy accessibility in clinical practice.
本研究旨在阐明术前血浆纤维蛋白原和血清白蛋白水平(即FA评分)对中国上尿路尿路上皮癌(UTUC)患者队列的预后价值。我们回顾性评估了2006年至2013年间接受手术的169例患者的临床病理数据。FA评分基于纤维蛋白原3.53g/L和白蛋白43.56g/L的临界值计算得出。采用Kaplan-Meier法评估总生存期和癌症特异性生存期,并通过对数秩检验检验曲线的等效性。Cox比例风险回归模型用于单因素和多因素分析。在单因素分析中,肿瘤大小、肿瘤分级、病理T分期和FA评分与总生存期和癌症特异性生存期显著相关,多因素Cox比例风险回归分析确定FA评分(评分1:HR=3.486,95%CI 1.358-8.948,P=0.009;HR=3.485,95%CI 1.363-8.913,P=0.009,分别)是总生存期和癌症特异性生存期的独立预测因素。术前FA评分的评估可被视为预测UTUC患者总生存期和癌症特异性生存期的独立预后因素。纤维蛋白原和白蛋白水平在临床实践中成本低且易于获取。